BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitro

References

• Calmette A, Bocquet A, Negre L. Contribution a l’etude du bacilli tuberculuex bilie. Ann Inst Pasteur. 1921;9:561–16.
   Google Scholar
• Gandhi NM, Morales A, Lamm DL. Bacillus calmette-Guerin immunotherapy for genitourinary cancer. BJU International. 2013 Aug;112(3):288–297. doi:10.1111/j.1464-410X.2012.11754.x.
   PubMed Web of Science ®Google Scholar
• Foster M, Hill PC, Setiabudiawan TP, Koeken VACM, Alisjahbana B, Crevel R. BCG-induced protection against Mycobacterium tuberculosis infection: evidence, mechanisms, and implications for next-generation vaccines. Immunol Rev. 2021 Mar 12;301(1):122–144. doi:10.1111/imr.12965.
   PubMed Web of Science ®Google Scholar
• Behr MA, Small PM. A historical and molecular phylogeny of BCG strains. Vaccine. 1999 Feb 26;17(7–8):915–922. doi:10.1016/S0264-410X(98)00277-1.
   PubMed Web of Science ®Google Scholar
• Gan C, Mostafid H, Khan MS, Lewis DJM. BCG immunotherapy for bladder cancer–the effects of substrain differences. Nat Rev Urol. 2013 Oct;10(10):580–588. doi:10.1038/nrurol.2013.194.
   PubMed Web of Science ®Google Scholar
• Zhang L, Ru HW, Chen FZ, Jin CY, Sun RF, Fan XY, et al. Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms. Mol Ther. 2016 Feb;24(2):398–405. doi:10.1038/mt.2015.216.
   PubMed Web of Science ®Google Scholar
• Zufferey C, Germano S, Dutta B, Ritz N, Curtis N. The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNgamma response in bacille calmette-guerin (BCG)-immunized infants. PloS one. 2013;8(10):e77334. doi:10.1371/journal.pone.0077334.
   PubMed Web of Science ®Google Scholar
• Roy A, Eisenhut M, Harris RJ, Gan C, Mostafid H, Khan MS, Lewis DJM. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. Bmj. 2014 Aug 5;349(aug04 5):g4643. doi:10.1136/bmj.g4643.
   PubMedGoogle Scholar
• Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010 Jun 25;59(RR–5):1–25.
   PubMedGoogle Scholar
• Rozot V, Nemes E, Geldenhuys H, Musvosvi M, Toefy A, Rantangee F, Makhethe L, Erasmus M, Bilek N, Mabwe S, et al. Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines. Commun Biol. 2020 Oct 9;3(1):563. doi:10.1038/s42003-020-01288-3.
   PubMed Web of Science ®Google Scholar
• Roy Chowdhury R, Vallania F, Yang Q, Lopez Angel CJ, Darboe F, Penn-Nicholson A, Rozot V, Nemes E, Malherbe ST, Ronacher K, et al. A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes. Nature. 2018 Aug;560(7720):644–648. doi:10.1038/s41586-018-0439-x.
   PubMed Web of Science ®Google Scholar
• Garcia-Cuesta EM, Esteso G, Ashiru O, López-Cobo S, Álvarez-Maestro M, Linares A, Ho MM, Martínez-Piñeiro L, T. Reyburn H, Valés-Gómez M, et al. Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes. Oncoimmunology. 2017;6(4):e1293212. doi:10.1080/2162402X.2017.1293212.
   PubMed Web of Science ®Google Scholar
• Suliman S, Geldenhuys H, Johnson JL, Hughes JE, Smit E, Murphy M, Toefy A, Lerumo L, Hopley C, Pienaar B, et al. Bacillus Calmette–Guérin (BCG) revaccination of adults with latent mycobacterium tuberculosis infection induces long-lived BCG-Reactive NK cell responses. J Immunol. 2016 Aug 15;197(4):1100–1110. doi:10.4049/jimmunol.1501996.
   PubMed Web of Science ®Google Scholar
• O’Neill LAJ, Netea MG. BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol. 2020 Jun;20(6):335–337. doi:10.1038/s41577-020-0337-y.
   PubMed Web of Science ®Google Scholar
• Mujal AM, Delconte RB, Sun JC. Natural killer cells: from innate to adaptive features. Annu Rev Immunol. 2021 Apr 26;39(1):417–447. doi:10.1146/annurev-immunol-101819-074948.
   PubMedGoogle Scholar
• Della Chiesa M, De Maria A, Muccio L, Bozzano F, Sivori S, Moretta L. Human NK cells and herpesviruses: mechanisms of recognition, response and adaptation. Front Microbiol. 2019;10:2297. doi:10.3389/fmicb.2019.02297.
   PubMed Web of Science ®Google Scholar
• Van Rhijn I, Moody DB. Donor unrestricted T cells: a shared human T cell response. J Immunol. 2015 Sep 1;195(5):1927–1932. doi:10.4049/jimmunol.1500943.
   PubMed Web of Science ®Google Scholar
• Kulicke CA, Lewinsohn DA, Lewinsohn DM. Clonal enrichments of Vdelta2- gammadelta T cells in Mycobacterium tuberculosis-infected human lungs. J Clin Invest. 2020 Jan 2;130(1):68–70. doi:10.1172/JCI133119.
   PubMed Web of Science ®Google Scholar
• Ogongo P, Steyn AJ, Karim F, Dullabh KJ, Awala I, Madansein R, Leslie A, Behar SM. Differential skewing of donor-unrestricted and gammadelta T cell repertoires in tuberculosis-infected human lungs. J Clin Invest. 2020 Jan 2;130(1):214–230. doi:10.1172/JCI130711.
   PubMed Web of Science ®Google Scholar
• Esteso G, Aguilo N, Julian E, Ashiru O, Ho MM, Martín C, Valés-Gómez M. Natural killer anti-tumor activity can be achieved by in vitro incubation with heat-killed BCG. Front Immunol. 2021;12:622995. doi:10.3389/fimmu.2021.622995.
   PubMed Web of Science ®Google Scholar
• Wagner JA, Rosario M, Romee R, Berrien-Elliott MM, Schneider SE, Leong JW, Sullivan RP, Jewell BA, Becker-Hapak M, Schappe T, et al. CD56bright NK cells exhibit potent antitumor responses following IL-15 priming. J Clin Invest. 2017 Nov 1;127(11):4042–4058. doi:10.1172/JCI90387.
   PubMed Web of Science ®Google Scholar
• Smith SG, Kleinnijenhuis J, Netea MG, Dockrell HM. Whole blood profiling of bacillus calmette-guerin-induced trained innate immunity in infants identifies epidermal growth factor, IL-6, platelet-derived growth factor-AB/BB, and natural killer cell activation. Front Immunol. 2017;8:644. doi:10.3389/fimmu.2017.00644.
   PubMed Web of Science ®Google Scholar
• Kleinnijenhuis J, Quintin J, Preijers F, Joosten LAB, Jacobs C, Xavier RJ, van der Meer JWM, van Crevel R, Netea MG. BCG-induced trained immunity in NK cells: role for non-specific protection to infection. Clin Immunol. 2014 Dec;155(2):213–219. doi:10.1016/j.clim.2014.10.005.
   PubMed Web of Science ®Google Scholar
• Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Cancer immunotherapy with gammadelta T cells: many paths ahead of us. Cell Mol Immunol. 2020 Sep;17(9):925–939. doi:10.1038/s41423-020-0504-x.
   PubMed Web of Science ®Google Scholar
• Fowler DW, Copier J, Wilson N, Dalgleish AG, Bodman-Smith MD. Mycobacteria activate gammadelta T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy. Cancer Immunol Immunother. 2012 Apr;61(4):535–547. doi:10.1007/s00262-011-1121-4.
   PubMed Web of Science ®Google Scholar
• Wesch D, Marx S, Kabelitz D. Comparative analysis of alpha beta and gamma delta T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate. Eur J Immunol. 1997 Apr;27(4):952–956. doi:10.1002/eji.1830270422.
   PubMed Web of Science ®Google Scholar
• Saura-Esteller J, de Jong M, King LA, Ensing E, Winograd B, de Gruijl TD, et al. Gamma delta T-cell based cancer immunotherapy: past-present-future [Mini Review]. Frontiers in Immunology. 2022 June 16;13:13.
   Web of Science ®Google Scholar
• Zhao Y, Niu C, Cui J. Gamma-delta (gammadelta) T cells: friend or foe in cancer development? J Transl Med. 2018 Jan 10;16(1):3. doi:10.1186/s12967-017-1378-2.
   PubMedGoogle Scholar
• Li Y, Li G, Zhang J, Wu X, Chen X. The dual roles of human gammadelta T cells: anti-Tumor or tumor-promoting. Front Immunol. 2020;11:619954. doi:10.3389/fimmu.2020.619954.
   PubMed Web of Science ®Google Scholar
• Chabab G, Barjon C, Bonnefoy N, Lafont V. Pro-tumor gammadelta T cells in human cancer: polarization, mechanisms of action, and implications for therapy. Front Immunol. 2020;11:2186. doi:10.3389/fimmu.2020.02186.
   PubMed Web of Science ®Google Scholar
• Caron J, Ridgley LA, Bodman-Smith M. How to train your dragon: harnessing gamma delta T cells antiviral functions and trained immunity in a pandemic era. Front Immunol. 2021;12:666983. doi:10.3389/fimmu.2021.666983.
   PubMed Web of Science ®Google Scholar
• Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev. 2008 Aug;32(5):821–841. doi:10.1111/j.1574-6976.2008.00118.x.
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Langerak AW, Bruggemann M, Evans PAS, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003 Dec;17(12):2257–2317. doi:10.1038/sj.leu.2403202.
   PubMed Web of Science ®Google Scholar
• Krangel MS. Mechanics of T cell receptor gene rearrangement. Curr Opin Immunol. 2009 Apr;21(2):133–139. doi:10.1016/j.coi.2009.03.009.
   PubMed Web of Science ®Google Scholar
• Boria I, Cotella D, Dianzani I, Santoro C, Sblattero D. Primer sets for cloning the human repertoire of T cell receptor variable regions. BMC Immunol. 2008 Aug 29;9(1):50. doi:10.1186/1471-2172-9-50.
   PubMedGoogle Scholar
• Spencer CT, Abate G, Sakala IG, Xia M, Truscott SM, Eickhoff CS, Linn R, Blazevic A, Metkar SS, Peng G, et al. Granzyme A produced by gamma(9)delta(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen. PLoS Pathog. 2013 Jan;9(1):e1003119. doi:10.1371/journal.ppat.1003119.
   PubMed Web of Science ®Google Scholar
• Qin G, Liu Y, Zheng J, Xiang Z, Ng IHY, Malik Peiris JS, Lau Y-L, Tu W. Phenotypic and functional characterization of human gammadelta T-cell subsets in response to influenza A viruses. J Infect Dis. 2012 Jun;205(11):1646–1653. doi:10.1093/infdis/jis253.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang C. The role of human gammadelta T cells in anti-tumor immunity and their potential for cancer immunotherapy. Cells. 2020 May 13;9(5):1206. doi:10.3390/cells9051206.
   PubMed Web of Science ®Google Scholar
• Becht E, McInnes L, Healy J, Dutertre C-A, Kwok IWH, Ng LG, Ginhoux F, Newell EW. Dimensionality reduction for visualizing single-cell data using UMAP. Nature Biotechnology. 2018 Dec 3; doi:10.1038/nbt.4314.
   PubMed Web of Science ®Google Scholar
• Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ, et al. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol. 2009 Apr;10(4):427–436. doi:10.1038/ni.1717.
   PubMed Web of Science ®Google Scholar
• Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. TN, Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol. 2000 Nov;1(5):433–440. doi:10.1038/80877.
   PubMed Web of Science ®Google Scholar
• Maruhashi T, Sugiura D, Okazaki IM, Okazaki T. LAG-3: from molecular functions to clinical applications. J Immunother Cancer. 2020 Sep;8(2):e001014. doi:10.1136/jitc-2020-001014.
   PubMed Web of Science ®Google Scholar
• Pizzolato G, Kaminski H, Tosolini M, Franchini DM, Pont F, Martins F, et al. Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVdelta1 and TCRVdelta2 gammadelta T lymphocytes. Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11906–11915. doi:10.1073/pnas.1818488116.
   PubMed Web of Science ®Google Scholar
• Park JH, Lee HK. Function of gammadelta T cells in tumor immunology and their application to cancer therapy. Exp Mol Med. 2021 Mar;53(3):318–327. doi:10.1038/s12276-021-00576-0.
   PubMed Web of Science ®Google Scholar
• Parker ME, Ciofani M. Regulation of gammadelta T cell effector diversification in the thymus. Front Immunol. 2020;11:42. doi:10.3389/fimmu.2020.00042.
   PubMed Web of Science ®Google Scholar
• Patil RS, Shah SU, Shrikhande SV, Goel M, Dikshit RP, Chiplunkar SV. IL17 producing gammadeltaT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients. Int J Cancer. 2016 Aug 15;139(4):869–881. doi:10.1002/ijc.30134.
   PubMed Web of Science ®Google Scholar
• Lawand M, Dechanet-Merville J, Dieu-Nosjean MC. Key features of GAMMA-Delta T-Cell subsets in human diseases and their immunotherapeutic Implications. Front Immunol. 2017;8:761. doi:10.3389/fimmu.2017.00761.
   PubMed Web of Science ®Google Scholar
• Felgueres MJ, Esteso G, Vales-Gomez M. Low dose cytokine-activated characterization and proliferation of anti-tumoral NK cells. Abstract at the Society for Natural Immunity Meeting NK2022: 50 Years of NK Cells, Bonita Springs, FL. 2022.
   Google Scholar
• Burnham RE, Zoine JT, Story JY, Garimalla SN, Gibson G, Rae A, et al. Characterization of donor variability for gammadelta T cell ex vivo expansion and development of an allogeneic gammadelta T cell immunotherapy. Front Med (Lausanne). 2020;7:588453. doi:10.3389/fmed.2020.588453.
   PubMed Web of Science ®Google Scholar
• Spencer CT, Abate G, Blazevic A, Hoft DF. Only a subset of phosphoantigen-Responsive γ 9 δ 2 T cells mediate protective tuberculosis immunity. J Immunol. 2008 Oct 1;181(7):4471–4484. doi:10.4049/jimmunol.181.7.4471.
   PubMed Web of Science ®Google Scholar
• Wang RN, Wen Q, He WT, Yang JH, Zhou CY, Xiong WJ, et al. Optimized protocols for gammadelta T cell expansion and lentiviral transduction. Mol Med Rep. 2019 Mar;19(3):1471–1480. doi:10.3892/mmr.2019.9831.
   PubMed Web of Science ®Google Scholar
• Nerdal PT, Peters C, Oberg HH, Zlatev H, Lettau M, Quabius ES, Sousa S, Gonnermann D, Auriola S, Olive D, et al. Butyrophilin 3A/CD277-dependent activation of human gammadelta T cells: accessory cell capacity of distinct leukocyte populations. J Immunol. 2016 Oct 15;197(8):3059–3068. doi:10.4049/jimmunol.1600913.
   PubMed Web of Science ®Google Scholar
• Workalemahu G, Wang H, Puan KJ, Nada MH MH, Kuzuyama T, Jones BD, et al. Metabolic engineering of Salmonella vaccine bacteria to boost human Vgamma2Vdelta2 T cell immunity. J Immunol. 2014 Jul 15;193(2):708–721. doi:10.4049/jimmunol.1302746.
   PubMed Web of Science ®Google Scholar
• Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, et al. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy. Cytotherapy. 2008;10(8):842–856. doi:10.1080/14653240802419328.
   PubMed Web of Science ®Google Scholar
• Rigau M, Ostrouska S, Fulford TS, Johnson DN, Woods K, Ruan Z, McWilliam HEG, Hudson C, Tutuka C, Wheatley AK, et al. Butyrophilin 2A1 is essential for phosphoantigen reactivity by gammadelta T cells. Science. 2020 Feb 7;367(6478). doi:10.1126/science.aay5516.
   PubMed Web of Science ®Google Scholar
• Fenn J, Ridgley LA, White A, Sarfas C, Dennis M, Dalgleish A, Reljic R, Sharpe S, Bodman-Smith M. Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid. Clin Exp Immunol. 2022 Jun 23;208(3):301–315. doi:10.1093/cei/uxac032.
   PubMed Web of Science ®Google Scholar
• Jonus HC, Burnham RE, Ho A, Pilgrim AA, Shim JJ, Doering CB, et al. Dissecting the cellular components of ex vivo gammadelta T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials. Oncoimmunology. 2022;11(1):2057012.
   PubMed Web of Science ®Google Scholar
• Beltra JC, Bourbonnais S, Bédard N, Charpentier T, Boulangé M, Michaud E, et al. IL2Rβ-dependent signals drive terminal exhaustion and suppress memory development during chronic viral infection. Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5444–53. doi:10.1073/pnas.1604256113.
   PubMed Web of Science ®Google Scholar
• Nishio N, Fujita M, Tanaka Y, Maki H, Zhang R, Hirosawa T, Demachi-Okamura A, Uemura Y, Taguchi O, Takahashi Y, et al. Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cells. J Immunother. 2012 Oct;35(8):598–606. doi:10.1097/CJI.0b013e31826a745a.
   PubMed Web of Science ®Google Scholar